Backup platform diversity
Production VMs run on Hypervisor A; immutable backups land on a different vendor’s hardened appliance so one hypervisor zero-day does not also unlock all recovery copies of the EHR.
Heterogeneity
Medium Risk
Complex
High Cost
SC-29 employs diverse system components (different vendors, operating systems, or technologies) in an organization-defined architecture to reduce the likelihood that a single vulnerability or supplier failure compromises the entire mission. Healthcare monocultures—one virtualization stack, one OS image everywhere, one cloud IAM path—turn a single ransomware playbook into an enterprise outage affecting ePHI availability.
Control Objective
Introduce intentional technology diversity in critical ePHI-supporting architecture where risk analysis shows monoculture concentration is unacceptable.
Implementation Guidance
- Identify monoculture concentration risks (hypervisor, OS, IdP, backup software, edge firewall).
- For high-impact layers, plan diversity (e.g., immutable backups on a different platform than production).
- Avoid diversity theater—two weak products are worse than one well-managed stack.
- Document supplier and platform diversity in supply-chain risk decisions (SR family).
- Keep operational complexity manageable; train staff on each platform.
- Apply heterogeneity especially to recovery and identity break-glass paths.
- Reassess after major consolidations/M&A IT mergers.
- Record Not Selected if small clinics accept monoculture risk explicitly.
Real-World Use Cases
How this control shows up in healthcare and HIPAA-covered environments.
Identity break-glass diversity
Primary cloud IdP outage: documented alternate admin path on a separate technology allows emergency clinical access decisions without total lockout.
Clinic Not Selected
A three-physician practice documents SC-29 Not Selected due to scale, focusing budget on backups and MFA instead of dual stacks.
Best Practices
- Target diversity at SPOF layers (backup, identity, boundary).
- Balance diversity vs operable complexity.
- Include in risk assessment explicitly.
- Prefer recovery-path diversity even if prod is uniform.
- Revisit after vendor consolidation.
- Document Not Selected when appropriate.
Common Gaps & Violations
- Claiming heterogeneity while everything shares one AD and one backup.
- Random product sprawl without architecture intent.
- No staff skilled on the "diverse" secondary platform.
- Diversity only on low-impact print servers.
- Ignoring supplier concentration risk.
Required Documentation
- Heterogeneity strategy / selection decision (SC-29)
- Architecture notes on diverse components
- Risk acceptance for remaining monocultures
- Skills/coverage for each platform
- Link to SR / CP evidence
How to Test & Validate
- Review architecture for single-vendor critical paths.
- Test recovery using the diverse backup platform.
- Tabletop IdP diversity / break-glass.
- Confirm secondary platforms are patched and owned.
- Validate SSP selection matches reality.
Audit Considerations
SC-29 is strategic. Assessors look for intentional diversity at critical layers—or a clear Not Selected rationale—not a shopping list of unused tools.
HIPAA Mapping
How this NIST control supports HIPAA Security Rule expectations.
- 164.308(a)(1) Risk Management — reduce likelihood of widespread ePHI system failure.
- 164.308(a)(7) Contingency Plan — diverse recovery capabilities support availability.
- 164.308(a)(8) Evaluation — periodic technical evaluation of architecture concentration.
- 164.312(a) Access Control — alternate auth paths may support emergency access design.
Compliance Tips
- Put monoculture findings in the risk register with treatment plans.
- Prioritize backup and identity diversity before desktop OS diversity.
- Align with cyber-insurance architecture questions.
Frequently Asked Questions
Does SC-29 require multiple EHR vendors?
No. Focus on infrastructure and supporting services where common exploits cascade; dual EHRs are rarely practical.
Is multi-cloud required?
Not necessarily—diversity can be platform/product within one cloud or on-prem.
When is Not Selected acceptable?
When risk analysis and leadership accept concentration risk and compensating controls are documented.
References & Resources
- NIST SP 800-53 Rev. 5 — SC-29
- Related controls: CP-9, CP-10, SR-3, RA-3, SC-7
Related Guidelines
Related controls that commonly accompany SC-29.
Need Help Implementing SC-29?
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.